IDENTIFYING THE MAXIMUM SAFE DOSE: A MULTIPLE TESTING APPROACH

References

• Tukey , J W , Ciminera , J L and Heyse , J F . 1985 . Testing the Statistical Certainty of a Response to Increasing Doses of a Drug . Biometrics , 41 : 295 – 301 .
   PubMed Web of Science ®Google Scholar
• Brown , K G and Erdreich , L S . 1989 . Statistical Uncertainty in the No-Observed-Adverse-Effect Level . Fundam. Appl. Toxicol. , 13 : 235 – 244 .
   PubMedGoogle Scholar
• Yanagawa , T , Kikuchi , Y and Brown , K G . 1994 . Statistical Issues on the No-Observed-Adverse-Effect Level in Categorical Response . Environ. Health Perspect. , 102 (suppl 1) : 95 – 101 .
   PubMedGoogle Scholar
• Yanagawa , T and Kikuchi , Y . 1995 . Determination of the No-Observed-Adverse-Effect Level by the AIC . Sankhya , B 57 : 285 – 297 .
   Google Scholar
• Tamhane , A C , Dunnett , C W , Wetherington , J D and Green , J W . 1998 . Multiple Test Procedure for Identifying a Safe Dose Evanston, IL : Preprint, Department of Statistics, Northwestern University .
   Google Scholar
• Hothorn , L A and Lehmacher , W . 1991 . A Simple Testing Procedure Control versus k Treatments for One-Sided Ordered Alternatives, with Application in Toxicology . Biometrical J. , 33 : 179 – 189 .
   Web of Science ®Google Scholar
• Tamhane , A C , Dunnett , C W and Hochberg , Y . 1996 . Multiple Test Procedures for Dose Finding . Biometrics , 52 : 21 – 37 .
   PubMed Web of Science ®Google Scholar
• Hothorn , L A , Neuhäuser , M and Koch , H F . 1997 . Analysis of Randomized Dose-Finding Studies: Closure Test Modifications Based on Multiple Contrast Tests . Biometrical J. , 39 : 467 – 479 .
   Web of Science ®Google Scholar
• Bross , I D . 1985 . Why Proof of Safety Is Much More Difficult than Proof of Hazard . Biometrics , 41 : 785 – 793 .
   PubMed Web of Science ®Google Scholar
• Millard , S P . 1987 . Proof of Safety vs. Proof of Hazard . Biometrics , 43 : 719 – 725 .
   PubMed Web of Science ®Google Scholar
• Stallard , N and Whitehead , A . 1996 . An Alternative Approach to the Analysis of Animal Carcinogenicity Studies . Regul. Toxicol. Pharmacol. , 23 : 244 – 248 .
   PubMed Web of Science ®Google Scholar
• Neuhäuser , M and Hothorn , L A . 1995 . “ Auswertung der Dosis-Wirkungs-Abhängigkeit des Ames Mutagenitätsassay bei direkter Kontrolle des Konsumentenrisikos. ” . In Medizinische Forschung und ärztliches Handeln. Edited by: Trampisch , H J and Lange , S . Vol. 80 , 113 – 116 . Munich, , Germany : MVM Medizin Verlag München . Medizin. Informatik, Biometrie and Epidemiologie
   Google Scholar
• Neuhäuser , M and Hothorn , L A . 1997 . The Control of the Consumer Risk in the Ames Assay . Drug Inf. J. , 31 : 363 – 368 .
   Google Scholar
• Hauschke , D . 1997 . Statistical Proof of Safety in Toxicological Studies . Drug Inf. J. , 31 : 357 – 362 .
   Google Scholar
• Hauschke , D and Hothorn , L A . 1998 . “ Safety Assessment in Toxicology Studies: Proof of Safety versus Proof of Hazard ” . In Design and Analysis of Animal Studies in Pharmaceutical Development Edited by: Chow , S C and Liu , J P . 197 – 226 . New York : Marcel Dekker, Inc. .
   Google Scholar
• Gaylor , D W . 1983 . The Use of Safety Factors for Controlling Risk . J. Toxicol. Environ. Health , 11 : 329 – 336 .
   PubMed Web of Science ®Google Scholar
• Leisenring , W and Ryan , L . 1992 . Statistical Properties of the NOAEL . Regul Toxicol Pharmacol. , 15 : 161 – 171 .
   PubMed Web of Science ®Google Scholar
• Murrell , J A , Portier , C J and Morris , R W . 1998 . Characterization Dose-Response I: Critical Assessment of the Benchmark Dose Concept . Risk Analysis , 18 : 13 – 26 .
   PubMed Web of Science ®Google Scholar
• Bauer , P . 1997 . A Note on Multiple Testing Procedures in Dose Finding . Biometrics , 53 : 1125 – 1128 .
   PubMed Web of Science ®Google Scholar
• Ruberg , S J . 1989 . Contrasts for Identifying the Minimum Effective Dose . J. Am. Stat. Assoc. , 84 : 816 – 822 .
   Web of Science ®Google Scholar
• Fligner , M A and Wolfe , D A . 1982 . Distribution-free Tests for Comparing Several Treatments with a Control . Statist. Neerlandica , 36 : 119 – 127 .
   Google Scholar
• Dunnett , C W and Tamhane , A C . 1991 . Step-down Multiple Tests for Comparing Treatments with a Control in Unbalanced One-Way Layouts . Statist. Med. , 10 : 939 – 947 .
   PubMed Web of Science ®Google Scholar
• Fraser , W D , Stamp , T C , Creek , R A , Sawyer , J P and Picot , C . 1997 . A Double-blind, Multicentre, Placebo-Controlled Study of Tiludronate in Paget's Disease of Bone . Postgrad. Med. J. , 73 : 496 – 502 .
   PubMed Web of Science ®Google Scholar
• Cantor , K P , Lynch , C P , Hildesheim , M E , Dosemeci , M , Lubin , J , Alavanja , M and Craun , G . 1998 . Drinking Water Source and Chlorination Byproducts I. Risk of Bladder Cancer . Epidemiology , 9 : 21 – 28 .
   PubMed Web of Science ®Google Scholar
• Chen , J J , Kodell , R L and Gaylor , D W . 1996 . “ Risk Assessment for Nonquantal Effects ” . In Toxicology and Risk Assessment Edited by: Fan , A M and Chang , L W . 503 – 513 . New York : Marcel Dekker, Inc. .
   Google Scholar
• Hsu , J C and Berger , R L . 1997 . “ Stepwise Confidence Intervals Without Multiplicity Adjustment for Dose Response, Multiple Endpoints and Toxicity Studies ” . In Technical Report, Department of Statistics Vol. 610 , Ohio State University .
   Google Scholar
• Crump , K S . 1995 . Calculation of Benchmark Doses from Continuous Data . Risk Analysis , 15 : 79 – 89 .
   Web of Science ®Google Scholar
• Shaffer , J P . 1986 . Modified Sequentially Rejective Multiple Test Procedures . J. Am. Stat. Assoc. , 81 : 826 – 831 .
   Web of Science ®Google Scholar
• Maurer , W , Hothorn , L A and Lehmacher , W . 1995 . “ Multiple Comparisons in Drug Clinical Trials and Preclinical Assays: A priori Ordered Hypotheses ” . In Biometrie in der chemisch-pharmazeutischen Industrie, Vol. 6 Edited by: Vollmar , J . 3 – 18 . Stuttgart, , Germany : Fischer .
   Google Scholar
• Casella , G and Berger , R L . 1990 . Statistical Inference Pacific Grove, CA : Wadsworth & Brooks .
   Google Scholar
• Dunnett , C W and Tamhane , A C . 1998 . Some New Multiple-Test Procedures for Dose Finding . J. Biopharm. Stat. , 8 : 353 – 366 .
   PubMedGoogle Scholar
• Bartholomew , D J . 1961 . Ordered Test in the Analysis of Variance . Biometrika , 48 : 325 – 332 .
   Web of Science ®Google Scholar
• Williams , D A . 1971 . A Test for Differences Between Treatment Means when Several Dose Levels Are Compared with a Zero Dose Control . Biometrics , 27 : 103 – 117 .
   PubMed Web of Science ®Google Scholar
• Mukerjee , H , Robertson , T and Wright , F T . 1986 . “ Multiple Contrast Tests for Testing Against a Simple Tree Ordering ” . In Advances in Order Restricted Statistical Inference Edited by: Dykstra , R . 203 – 230 . Berlin, , Germany : Springer .
   Google Scholar
• Tukey , J W , Ciminera , J L and Heyse , J F . 1985 . Testing the Statistical Certainty of a Response to Increasing Doses of a Drug . Biometrics , 41 : 295 – 301 .
   PubMed Web of Science ®Google Scholar
• McDermott , M P and Mudholkar , G S . 1993 . A Simple Approach to Testing Homogeneity of Order-Constrained Means . J. Am. Stat. Assoc. , 88 : 1371 – 1379 .
   Google Scholar
• Hothorn , L A and Hilton , J F . 1999 . Analyzing Real Data Randomized Clinical Dose Finding Studies: Robust Estimation of the Minimum Effective Dose . ASA Proceedings, Biopharm. Section 1998 , : 91 – 94 .
   Google Scholar
• 1994 . “ CPMP Working Party on Efficacy of Medical Products ” . In Note for Guidance: “Biostatistical Methodology in Clinical Trials in Applications for Marketing Authorizations for Medicinal Products London, , England : CPMP .
   Google Scholar
• Hahn , G J and Meeker , W Q . 1991 . Statistical Intervals: Guide for Practitioners 1 – 392 . New York : John Wiley & Sons .
   Google Scholar
• Gaylor , D W and Slikker , W L . 1990 . Risk Assessment for Neurotoxic Effects . Neurotoxicology , 11 : 211 – 218 .
   PubMed Web of Science ®Google Scholar
• Erickson , W P and McDonald , L L . 1995 . Tests for Bioequivalence of Control Media and Test Media in Studies of Toxicity . Environ. Toxicol. Chem. , 14 : 1247 – 1256 .
   Web of Science ®Google Scholar
• Hauschke , D , Kieser , M and Hothorn , L A . 1999 . Proof of Safety in Toxicology Based on the Ratio of Two Means for Normally Distributed Data . Biometr. J. , 41 : 295 – 304 .
   Web of Science ®Google Scholar
• Cariello , N F and Piegorsch , W W . 1996 . The Ames Test: The Two-fold Rule Revisited . Mutat. Res. , 369 : 23 – 31 .
   PubMed Web of Science ®Google Scholar
• Sasabuchi , S . 1988 . “ A Multivariate One-Sided Test with Composite Hypotheses Determined by Linear Inequalities when the Covariance Matrix Has an Unknown Scale Factor ” . In Memoirs of the Faculty of Science Vol. 42 , 9 – 19 . Kyushu, , Japan : Kyushu University, Series A, Mathematics .
   Google Scholar
• Fieller , E . 1954 . Some Problems in Interval Estimation . J. Royal Stat. Soc. , B16 : 175 – 185 .
   Google Scholar
• Kieser , M and Hauschke , D . 1999 . Approximate Sample Sizes for Testing Hypotheses About the Ratio and Difference of Two Means . J. Biopharm. Stat. , 9 : 641 – 650 .
   PubMedGoogle Scholar
• Berger , R L and Hsu , J C . 1996 . Bioequivalence Trials, Intersection-Union Tests and Equivalence Confidence Sets . Stat. Sci. , 11 : 283 – 302 .
   Web of Science ®Google Scholar
• Hollander , M and Wolfe , D A . 1976 . Nonparametric Statistical Methods New York : John Wiley & Sons .
   Google Scholar
• Vuorinen , J and Tuominen , J . 1994 . Fieller's Confidence Intervals for the Ratio of Two Means in the Assessment of Average Bioequivalence from Crossover Data . Stat. Med. , 13 : 2531 – 2545 .
   PubMed Web of Science ®Google Scholar
• Blackwelder , W C . 1982 . Proving the Null Hypothesis in Clinical Trials . Contr. Clin. Trials , 3 : 345 – 353 .
   PubMedGoogle Scholar
• Dunnett , C W and Gent , M . 1977 . Significance Testing to Establish Equivalence Between Treatments with Special Reference to Data in the Form of 2 × 2 Tables . Biometrics , 33 : 593 – 602 .
   PubMed Web of Science ®Google Scholar
• Rodary , C , Com-Nougue , C and Tournade , M . 1989 . How to Establish Equivalence between Treatments: A One-Sided Clinical Trial in Paediatric Oncology . Stat. Med. , 8 : 593 – 598 .
   PubMed Web of Science ®Google Scholar
• Farrington , C P and Manning , G . 1990 . Test Statistics and Sample Size Formulae for Comparative Binomial Trials with Null-Hypothesis of Non-Zero Risk Differences or Non-Unity Relative Risk . Stat. Med. , 9 : 1447 – 1454 .
   PubMed Web of Science ®Google Scholar
• Chan , I S.F . 1998 . Exact Tests of Equivalence and Efficacy with a Non-Zero Lower Bound for Comparative Studies . Stat. Med. , 17 : 1403 – 1413 .
   PubMed Web of Science ®Google Scholar
• Tu , D . 1998 . On the Use of the Ratio or Odds Ratio of Cure Rates in Therapeutic Equivalence Clinical Trials with Binary Endpoints . J. Biopharm. Stat. , 8 : 263 – 282 .
   PubMedGoogle Scholar